# Coty Inc.: overview

COTY · NYSE · CIK 1024305 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/coty.md) · [Financials](/companies/coty/financials.md) · [Filings](/companies/coty/filings.md) · [Insiders](/companies/coty/insiders.md)

Latest reported revenue: [$1.27bn](/filings/0001024305-26-000048.md) for Q4 FY2026, three months to 2026-06-30, from the 10-K filed Aug 20, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001024305-26-000048).

## Last eight quarters

| Line item | Unit | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,672](/filings/0001024305-25-000065.md) | [1,670](/filings/0001024305-26-000014.md) | [1,299](/filings/0001024305-26-000029.md) | [1,252 d](/filings/0001024305-26-000048.md) | [1,577](/filings/0001024305-25-000065.md) | [1,679](/filings/0001024305-26-000014.md) | [1,282](/filings/0001024305-26-000029.md) | [1,269 d](/filings/0001024305-26-000048.md) |
| Gross margin | % | [65.5%](/filings/0001024305-25-000065.md) | [66.7%](/filings/0001024305-26-000014.md) | [64.1%](/filings/0001024305-26-000029.md) | [62.3% d](/filings/0001024305-26-000048.md) | [64.5%](/filings/0001024305-25-000065.md) | [63.8%](/filings/0001024305-26-000014.md) | [61.8%](/filings/0001024305-26-000029.md) | [60.9% d](/filings/0001024305-26-000048.md) |
| Operating margin | % | [14.2%](/filings/0001024305-25-000065.md) | [16.1%](/filings/0001024305-26-000014.md) | [(21.6%)](/filings/0001024305-26-000029.md) | [1.2% d](/filings/0001024305-26-000048.md) | [11.7%](/filings/0001024305-25-000065.md) | [8.8%](/filings/0001024305-26-000014.md) | [(29.0%)](/filings/0001024305-26-000029.md) | [(3.4%) d](/filings/0001024305-26-000048.md) |
| Net margin | % | [5.0%](/filings/0001024305-25-000065.md) | [1.4%](/filings/0001024305-26-000014.md) | [(31.2%)](/filings/0001024305-26-000029.md) | [(5.5%) d](/filings/0001024305-26-000048.md) | [4.3%](/filings/0001024305-25-000065.md) | [(7.4%)](/filings/0001024305-26-000014.md) | [(31.8%)](/filings/0001024305-26-000029.md) | [(11.1%) d](/filings/0001024305-26-000048.md) |
| Diluted EPS | $ per share | [0.09](/filings/0001024305-25-000065.md) | [0.02](/filings/0001024305-26-000014.md) | [(0.47)](/filings/0001024305-26-000029.md) | not reported | [0.07](/filings/0001024305-25-000065.md) | [(0.14)](/filings/0001024305-26-000014.md) | [(0.47)](/filings/0001024305-26-000029.md) | not reported |
| Free cash flow | $m | [(7.9)](/filings/0001024305-25-000065.md) | [419 d](/filings/0001024305-26-000014.md) | [(168) d](/filings/0001024305-26-000029.md) | [34.9 d](/filings/0001024305-26-000048.md) | [11.2](/filings/0001024305-25-000065.md) | [513 d](/filings/0001024305-26-000014.md) | [(249) d](/filings/0001024305-26-000029.md) | [72.6 d](/filings/0001024305-26-000048.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,304](/filings/0001024305-24-000035.md) | [5,554](/filings/0001024305-25-000030.md) | [6,118](/filings/0001024305-26-000048.md) | [5,893](/filings/0001024305-26-000048.md) | [5,807](/filings/0001024305-26-000048.md) |
| Gross margin | % | [63.5%](/filings/0001024305-24-000035.md) | [63.9%](/filings/0001024305-25-000030.md) | [64.4%](/filings/0001024305-26-000048.md) | [64.8%](/filings/0001024305-26-000048.md) | [62.9%](/filings/0001024305-26-000048.md) |
| Operating margin | % | [4.5%](/filings/0001024305-24-000035.md) | [9.8%](/filings/0001024305-25-000030.md) | [8.9%](/filings/0001024305-26-000048.md) | [4.1%](/filings/0001024305-26-000048.md) | [(1.4%)](/filings/0001024305-26-000048.md) |
| Net margin | % | [4.9%](/filings/0001024305-24-000035.md) | [9.1%](/filings/0001024305-25-000030.md) | [1.5%](/filings/0001024305-26-000048.md) | [(6.2%)](/filings/0001024305-26-000048.md) | [(10.4%)](/filings/0001024305-26-000048.md) |
| Diluted EPS | $ per share | [0.08](/filings/0001024305-24-000035.md) | [0.57](/filings/0001024305-25-000030.md) | [0.09](/filings/0001024305-26-000048.md) | [(0.44)](/filings/0001024305-26-000048.md) | [(0.70)](/filings/0001024305-26-000048.md) |
| Free cash flow | $m | [553](/filings/0001024305-24-000035.md) | [403](/filings/0001024305-25-000030.md) | [369](/filings/0001024305-26-000048.md) | [278](/filings/0001024305-26-000048.md) | [348](/filings/0001024305-26-000048.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/coty/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2021-09-10 | [KKR Group Partnership L.P.](/insiders/1472698.md) | 10% owner | Sale (S) | 50,000,088 | $8.39 | $419.5m | [Form 4](/filings/0001140361-21-030950.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $155.5m | 72,002,396 |  | Added +19,531,900 |
| [BNP PARIBAS FINANCIAL MARKETS](/funds/1166588.md) | 2026-06-30 | $63.0m | 29,156,131 |  | Reduced −445,853 |
| [CREDIT AGRICOLE S A](/funds/1191672.md) | 2026-06-30 | $55.3m | 25,610,163 |  | Added +10,000,000 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $55.1m | 25,525,223 |  | Added +5,667,884 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $38.3m | 17,748,868 |  | Added +1,761,822 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $34.4m | 15,938,631 |  | Added +4,697,222 |
| [Banco Santander, S.A.](/funds/891478.md) | 2026-06-30 | $28.3m | 13,112,758 |  | Reduced −10,000,000 |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $26.8m | 12,413,619 |  | Reduced −399,343 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $25.7m | 11,888,134 |  | Reduced −1,717,585 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $20.2m | 9,357,257 |  | Added +2,750,969 |

## Recent filings

[All 1,178 filings](/companies/coty/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-24 | 20:21 ET | [DEF 14A](/filings/0001024305-26-000060.md) | Proxy statement, period 2026-06-30 | 0001024305-26-000060 |
| 2026-09-11 | 21:10 ET | [8-K](/filings/0001024305-26-000054.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001024305-26-000054 |
| 2026-08-20 | 21:15 ET | [8-K](/filings/0001024305-26-000050.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001024305-26-000050 |
| 2026-08-20 | 20:31 ET | [10-K](/filings/0001024305-26-000048.md) | Annual report, period 2026-06-30 | 0001024305-26-000048 |
| 2026-08-19 | 20:31 ET | [8-K](/filings/0001024305-26-000045.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001024305-26-000045 |
| 2026-07-07 | 20:17 ET | [8-K](/filings/0001024305-26-000038.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001024305-26-000038 |
| 2026-07-02 | 20:36 ET | [8-K](/filings/0001024305-26-000036.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001024305-26-000036 |
| 2026-05-05 | 20:38 ET | [10-Q](/filings/0001024305-26-000029.md) | Quarterly report, period 2026-03-31 | 0001024305-26-000029 |
| 2026-05-05 | 20:31 ET | [8-K](/filings/0001024305-26-000028.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001024305-26-000028 |
| 2026-03-18 | 20:33 ET | [8-K](/filings/0001024305-26-000022.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001024305-26-000022 |

## Latest annual report

[Form 10-K for the fiscal year ended Jun 30, 2026](/filings/0001024305-26-000048.md), filed Aug 20, 2026.

## Forecast league

Q1 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/9e7059f7-f8ee-4a13-94f9-fa7ec37d635c)

## About the filer

- CIK: 1024305
- Tickers: COTY
- Exchange: NYSE
- SIC code: 2844 Perfumes, Cosmetics & Other Toilet Preparations
- State of incorporation: not reported
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.